Wells Fargo analyst Larry Biegelsen raised his price target for Stryker to $219 from $214 following his monthly MAKO Surgeon Tracker, that analyzes trends in surgeon training. The analyst notes that surgeon training for Stryker's MAKO Total Knee Application was up 1.2% in March month over month as compared to up 2.7% in February. There is typical quarter-to-quarter variation in surgeon training and Biegelsen expects normalized growth going forward versus the high-growth seen in the initial quarters post launch. The analyst continues to believe there is runway for growth as MAKO remains vastly underpenetrated both from a system placement and procedure volume standpoint, globally. He reiterates an Outperform rating on the shares.